fetal-monitoring
(3)
Neil Ray
Neil P. Ray, MD is a board-certified pediatric anesthesiologist who traded the operating room for a startup. As founder and CEO of Raydiant Oximetry, he is building Lumerah, a non-invasive fetal pulse oximeter that reads a baby's oxygen levels through the mother's abdomen, and Daisy, a surgical device to prevent postpartum hemorrhage. His goal: retire a 50-year-old fetal monitor he calls no better than a coin toss, and cut the number of unnecessary C-sections that follow from it.
Bloomlife
Bloomlife is a San Francisco maternal health company that pairs FDA-cleared wearable sensors with a connected-care platform so high-risk pregnancies can be monitored from home. Born from a co-founder's own NICU experience, the company shifts prenatal care out of the clinic and into the living room - tracking fetal heart rate, blood pressure and glucose, then feeding the data to clinicians through risk-stratification tools meant to catch complications earlier.
Raydiant Oximetry, Inc.
Raydiant Oximetry is a clinical-stage medical device company building Lumerah, a noninvasive, transabdominal fetal pulse oximeter that measures a baby's blood-oxygen levels during labor. By giving obstetricians a direct read on fetal oxygenation - rather than the coin-flip guesswork of conventional fetal heart-rate monitors - the company aims to cut unnecessary C-sections and reduce maternal and neonatal harm. It holds FDA Breakthrough Device designation and is partnered with GE HealthCare.